Centene posted a net loss of $6.6 billion in the third quarter after recording a massive charge to reflect the company’s waning value amid challenging market conditions, including Republican cuts to ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. On July 1, Centene withdrew its 2025 guidance following an ...

Centene's stock has plummeted due to surging medical costs and a surprise Q2 loss. Despite new, lower 2025 guidance causing a slight pop, the company faces "hurricane level headwinds" like potential ...